読み込み中
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
前日終値
$13.00
+$1.66 · +14.64%
日中の時刻はETです。市場データは遅延する場合があります。
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
日中レンジ
現在 $13.00
52週レンジ
現在 $13.00
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
47
適正価値
センチメント
49
まちまち
リスク
72
高リスク
モメンタム
45
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
日中レンジ
現在 $13.00
52週レンジ
現在 $13.00
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 1.7億 USD | 2.27億 USD | 2.51億 USD | 4.78億 USD | 3.14億 USD |
| 売上原価 | 3152.1万 USD | 3854.9万 USD | 5400.5万 USD | 2.04億 USD | 1.3億 USD |
| 粗利益 | 1.39億 USD | 1.88億 USD | 1.97億 USD | 2.73億 USD | 1.84億 USD |
| 研究開発 | 2.44億 USD | 4.24億 USD | 5.81億 USD | 10.53億 USD | 11.5億 USD |
| 販売・一般管理 | 1.83億 USD | 2.46億 USD | 3.85億 USD | 14.3億 USD | 8.63億 USD |
| 営業費用 | 4.54億 USD | 7.48億 USD | 10.62億 USD | 24.82億 USD | 20.13億 USD |
| 受取利息 | 2261.6万 USD | 3861.2万 USD | 5721.7万 USD | 2026.2万 USD | 83.7万 USD |
| 支払利息 | — | 9.4万 USD | 9.3万 USD | 10.6万 USD | 237.3万 USD |
| 減価償却費と償却費 | 5899万 USD | 6302万 USD | 7155.4万 USD | 4255.2万 USD | 2907.6万 USD |
| 営業利益 | −3.15億 USD | −5.6億 USD | −8.64億 USD | −22.09億 USD | −18.28億 USD |
| 純利益 | −3.13億 USD | −5.47億 USD | −8.93億 USD | −21.05億 USD | −18.3億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
iShares Russell 2000 ETFIWM1450.54万0.02%787.4億 USD0.19%$278.94+0.49%
Vanguard Morningstar Total Stock Market ETFVTI1014.59万0.00%2.3兆 USD0.03%$381.94+0.63%
ROBO Global Artificial Intelligence ETFTHNQ475.89万0.93%5.11億 USD0.75%$98.57+1.39%
iShares Biotechnology ETFIBB426.18万0.04%108.2億 USD0.44%$206.49+3.00%
Vanguard Extended Market ETFVXF379.89万0.00%954億 USD0.05%$235+0.80%
State Street SPDR S&P Kensho New Economies Composite ETFKOMP369.8万0.14%26.06億 USD0.20%$66.35+1.13%
Schwab U.S. Small-Cap ETFSCHA307.91万0.01%218.24億 USD0.03%$32.79+0.40%
Dimensional - US Small Cap ETFDFAS216.75万0.01%338.69億 USD0.31%$78.35+0.32%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIROBO Global Artificial Intelligence ETFTHNQiShares Biotechnology ETFIBBVanguard Extended Market ETFVXFState Street SPDR S&P Kensho New Economies Composite ETFKOMPSchwab U.S. Small-Cap ETFSCHADimensional - US Small Cap ETFDFASAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
